D.E. Shaw & Co’s Actinium Pharmaceuticals ATNM Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-29,337
| Closed | -$217K | – | 3151 |
|
|
2024
Q2 | $217K | Buy |
+29,337
| New | +$217K | ﹤0.01% | 2808 |
|
|
2023
Q4 | – | Sell |
-18,002
| Closed | -$107K | – | 3098 |
|
|
2023
Q3 | $107K | Sell |
18,002
-10,752
| -37% | -$63.7K | ﹤0.01% | 2664 |
|
|
2023
Q2 | $213K | Sell |
28,754
-12,144
| -30% | -$90.1K | ﹤0.01% | 2593 |
|
|
2023
Q1 | $386K | Sell |
40,898
-236,222
| -85% | -$2.23M | ﹤0.01% | 2603 |
|
|
2022
Q4 | $2.95M | Buy |
277,120
+239,196
| +631% | +$2.55M | ﹤0.01% | 1809 |
|
|
2022
Q3 | $280K | Buy |
37,924
+20,600
| +119% | +$152K | ﹤0.01% | 3096 |
|
|
2022
Q2 | $83K | Sell |
17,324
-5,711
| -25% | -$27.4K | ﹤0.01% | 3589 |
|
|
2022
Q1 | $118K | Sell |
23,035
-2,438
| -10% | -$12.5K | ﹤0.01% | 3727 |
|
|
2021
Q4 | $153K | Sell |
25,473
-2,646
| -9% | -$15.9K | ﹤0.01% | 3558 |
|
|
2021
Q3 | $249K | Buy |
+28,119
| New | +$249K | ﹤0.01% | 3154 |
|
|
2021
Q1 | – | Sell |
-64,181
| Closed | -$501K | – | 2942 |
|
|
2020
Q4 | $501K | Buy |
+64,181
| New | +$501K | ﹤0.01% | 2284 |
|